Should You Buy This Small Cap US Stock-DAVA

Acrobull Canada Advisory Inc.

March 19			2025
Name	Ticker	Sector/Industry		Market Cap	Risk Factor
Endava Plc.	DAVA-NYSE	Technology		$994 Million	Medium

Endava PLC, a publicly traded software development company situated in London, United Kingdom, was founded in 2000. It provides digital transformation consulting, agile software development services, and various automation solutions.

Recent Highlights

Recent Highlights- In Q2 FY2025, revenue distribution showed North America at 39%, Europe at 24%, the United Kingdom at 32%, and other regions at 5%. This is an increase from the previous year’s figures of 31% for North America, 26% for Europe, 34% for the United Kingdom, and 9% for the rest of the world during the same quarter.

For Q2 FY2025, the revenue breakdown was 19% from Payments, 19% from BCM, 9% from Insurance, 19% from TMT, 9% from Mobility, 12% from Healthcare, and 13% from Other. In contrast, the corresponding period last year indicated 26% from Payments, 14% from BCM, 8% from Insurance, 23% from TMT, 11% from Mobility, 4% from Healthcare, and 14% from other.

Second Quarter 2025 Highlights

Income for Q2 FY2025 was £195.6 million, an increment of 6.6% compared to £183.6 million within the same period within the earlier year.

Income increment at consistent money (a non-IFRS degree)* was 9.1% for Q2 FY2025.

Benefit some time recently assess for Q2 FY2025 was £2.5 million, compared to £10.6 million within the same period within the earlier year.

Balanced benefit some time recently assess (a non-IFRS degree)* for Q2 FY2025 was £21.8 million, or 11.2% of income, compared to £22.7 million, or 12.4% of income, within the same period within the earlier year.

Benefit for the period was £6.9 million, coming about in a weakened profit per share ("EPS") of £0.11, compared to benefit of £8.3 million and weakened EPS of £0.14 within the same period within the earlier year.

Stock Observation- The company has reported second quarter financial results in good shape and also projected revenue increase for the third quarter. The RSI level for the stock is at 42 hence showing close oversold conditions. However right entry is needed to buy the stock.

Risk Involved- Financial performance of the company may have an impact on the company stock performance.

Considering all the factors and financials of the company Acrobull Canada Advisory Inc. maintains Customer Choose Watch for the stock.

Disclaimer- Though our research is fundamentally and technically based on Acrobull Canada Advisory Inc. only provides general advice on the stocks and it is imperative for the investors to do the risk assessment for themselves before investing as Acrobull Canada Advisory Inc. would not be liable for any loss or profit arising out through the investment made by the investors on our recommendations.

It is also advisable for the investors to consult with Financial Advisor, Broker or to seek any legal assistance as the research conducted by Acrobull Canada Advisory Inc. is factually based and recommendations are given in accordance with that, but it is imperative to understand that Acrobull Canada Advisory Inc. does not guarantee returns.

Acrobull Recommendation Based on Evaluation

Current Market Price	$22.32 USD
Acrobull Recommendation	Watch, Buy at $21.45 USD
Target Price	$24.25 USD
RSI Level	14 Day RSI 42
Total Shares Outstanding	45.38 Million
Shares held by Insiders Risk Factor Stop Loss	0.58% Medium 5%